Codexis to Participate in TD Cowen 46th Annual Health Care Conference

Rhea-AI Summary

Codexis (NASDAQ: CDXS) will attend the TD Cowen 46th Annual Health Care Conference in Boston March 2-4, 2026. Management will join a fireside chat on March 3, 2026 at 11:50 am ET. A live webcast will be available on the company's Investor Relations site and replayed for 90 days.

Key Figures

Conference dates: March 2–4, 2026 Fireside chat time: 11:50 am ET Replay period: 90 days +5 more

8 metrics

Conference dates March 2–4, 2026 TD Cowen 46th Annual Health Care Conference

Fireside chat time 11:50 am ET Management presentation on March 3, 2026

Replay period 90 days Archived webcast availability after event

Current price $1.20 Prior to conference participation news

52-week high $4.46 Pre-news 52-week range upper bound

52-week low $1.12 Pre-news 52-week range lower bound

Market cap $108,389,260 Equity value prior to conference update

Short interest 14.97% Reported short interest as of latest data

Market Reality Check

Price: $1.20 Vol: Volume 1,380,538 vs 20-da...

normal vol

$1.20 Last Close

Volume Volume 1,380,538 vs 20-day average 1,241,881 suggests modestly elevated trading activity before this conference update. normal

Technical Shares at $1.20, trading below the 200-day MA of $2.25 and well under the $4.46 52-week high.

Peers on Argus

Peers showed mixed moves: PRQR +3.55%, ACIU +0.67%, SLN -2.84%, VOR -1.84%, OABI...

Peers showed mixed moves: PRQR +3.55%, ACIU +0.67%, SLN -2.84%, VOR -1.84%, OABI flat, indicating stock-specific rather than sector-wide drivers.

Historical Context

5 past events · Latest: Feb 10 (Positive)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Feb 10	Quality certification	Positive	-3.1%	ISO 9001:2015 certification for HQ, R&D labs, and non-GMP manufacturing.
Jan 07	Platform evaluation deal	Positive	-1.2%	Axolabs evaluation agreement for ECO Synthesis oligonucleotide platform.
Nov 10	GMP facility lease	Positive	+3.5%	Lease of 34,000 sq ft GMP site to expand internal production.
Nov 06	Earnings and restructuring	Negative	-5.3%	Q3 2025 results with revenue decline, layoffs, and cost actions.
Oct 29	Platform evaluation deal	Positive	-6.6%	Nitto Denko Avecia evaluation of ECO Synthesis for siRNA manufacturing.

Pattern Detected

Recent partnership and certification news often saw negative next-day reactions, while capacity expansion and a weaker earnings print aligned with their respective price moves.

Recent Company History

Over the last several months, Codexis announced quality and capacity milestones and new platform evaluations. Highlights include ISO 9001:2015 certification on Feb 10, 2026, multiple ECO Synthesis® evaluation agreements with Axolabs and Nitto Denko Avecia, and a lease for a 34,000 sq ft GMP facility announced on Nov 10, 2025. The Q3 2025 earnings on Nov 6, 2025 detailed restructuring and a cash runway extension. Today’s conference participation fits into this ongoing effort to showcase the ECO Synthesis platform and broader capabilities.

Market Pulse Summary

This announcement highlights Codexis’s participation in a major healthcare conference, including a f...

Analysis

This announcement highlights Codexis’s participation in a major healthcare conference, including a fireside chat and webcast access for investors. In recent months, the company reported ECO Synthesis® evaluation agreements, ISO 9001:2015 certification, and a new GMP facility lease, alongside restructuring and a cash runway extension. Investors may focus on how management uses this forum to elaborate on these developments, clarify demand for the platform, and frame next operational milestones following prior strategic updates.

AI-generated analysis. Not financial advice.

REDWOOD CITY, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable manufacturing of complex therapeutics, today announced the Company will attend the TD Cowen 46^th Annual Health Care Conference, being held March 2-4, 2026, in Boston, Massachusetts.

Management will participate in a fireside chat on Tuesday, March 3, 2026, at 11:50 am ET. A live webcast of the event will be available in the Investor Relations section of the Company’s website, https://ir.codexis.com. A replay will be archived for 90 days following the event.

About Codexis

Codexis is a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, leveraging its proprietary CodeEvolver^® technology platform to discover, develop and enhance novel, high-performance enzymes. Codexis enzymes solve for real-world challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis^® manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis’ unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. For more information, visit https://www.codexis.com.

For More Information

Investor Contact
Georgia Erbez
(650) 421-8100
ir@codexis.com

FAQ

When will Codexis (CDXS) present at the TD Cowen 46th Annual Health Care Conference?

Codexis management will present in a fireside chat on March 3, 2026 at 11:50 am ET. According to the company, the session is part of the conference running March 2–4, 2026 in Boston and targets investors and analysts.

How can investors watch the Codexis (CDXS) webcast from TD Cowen on March 3, 2026?

Investors can watch the live webcast via the company's Investor Relations website at ir.codexis.com. According to the company, the live stream will be available during the March 3, 2026 fireside chat and archived for 90 days.

Will Codexis (CDXS) make a replay available after the TD Cowen conference?

Yes. According to the company, a replay of the webcast will be archived on the Investor Relations site for 90 days following the event, allowing investors to view the presentation after March 3, 2026.

What topics will Codexis (CDXS) likely cover at the TD Cowen Health Care Conference on March 3, 2026?

The company will likely discuss its enzymatic solutions and business developments in manufacturing complex therapeutics. According to Codexis, management will present company strategy and investor-focused updates during the fireside chat.

Where and when is the TD Cowen 46th Annual Health Care Conference that Codexis (CDXS) will attend?

The conference takes place in Boston, Massachusetts, from March 2–4, 2026. According to the company, Codexis will participate with management appearing in a March 3, 2026 fireside chat at 11:50 am ET.